Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-term protection in children with meningococcal C conjugate vaccination: lessons learned

1 Dec 2006

Abstract excerpt

Owing to an increase in group C disease, extensive prelicensure studies have been funded by both the UK Department of Health and vaccine manufacturers. These demonstrated the safety and immunogenicity of three candidate meningococcal group C conjugate (MCC) vaccines (two conjugated to CRM(197) and one to tetanus toxoid) in the targeted age groups. Induction of immunological memory in infants and young children...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacterial Infections and Vaccines
Share to Influenza Virus Research Studies
Share to Pneumonia and Respiratory Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17184222
DOI: 10.1586/14760584.5.6.851

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long-term protection in children with meningococcal C conjugate vaccination: lessons learnedPMID 17184222Read ↗

Influence of Prior Meningococcal C Polysaccharide Vaccination on the Response and Generation of Memory after Meningococcal C Conjugate Vaccination in Young ChildrenSemantic proximity Read ↗

Serological Basis for Use of Meningococcal Serogroup C Conjugate Vaccines in the United Kingdom: Reevaluation of Correlates of ProtectionSemantic proximity Read ↗

Immunogenicity and safety of a booster dose of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adolescents and adults: a Phase III randomized studySemantic proximity Read ↗

No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and WalesSemantic proximity Read ↗

History of meningococcal vaccines and their serological correlates of protectionSemantic proximity Read ↗

Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil.Semantic proximity Read ↗

Common Genetic Variations Associated with the Persistence of Immunity following Childhood ImmunizationSemantic proximity Read ↗

Gestational pertussis vaccination and the infant’s cellular immune response against whole-cell pertussis vaccine in the first year of lifeSemantic proximity Read ↗

Targeted vaccination of teenagers following continued rapid endemic expansion of a single meningococcal group W clone (sequence type 11 clonal complex), United Kingdom 2015.Semantic proximity Read ↗

Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation.Semantic proximity Read ↗

The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of Bordetella pertussisSemantic proximity Read ↗

Immunogenicity of Two Investigational Serogroup B Meningococcal Vaccines in the First Year of LifeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.